114 related articles for article (PubMed ID: 2445665)
1. Analysis of immunity to infection with Salmonella typhimurium in outbred mice. II. Isolation and immunogenicity of the protective non-O antigenic component from ribosomal vaccine.
Kita E; Emoto M; Katsui N; Nishi K; Yasui K; Yasui K; Kashiba S
Immunology; 1987 Oct; 62(2):235-40. PubMed ID: 2445665
[TBL] [Abstract][Full Text] [Related]
2. Analysis of immunity to infection with Salmonella typhimurium in outbred mice. I. Requirement of the antibody to non-O antigen for protection in mice that are not protected by the RNA-rich vaccine.
Kita E; Nishi K; Emoto M; Katsui N; Yasui K; Yasui K; Kashiba S
Immunology; 1987 Aug; 61(4):535-41. PubMed ID: 2450832
[TBL] [Abstract][Full Text] [Related]
3. Immunogenic dialyzable factor derived from a ribosomal fraction of Salmonella typhimurium. I. Preparation of the protective dialyzable factor from the ribosomal fraction by the freeze-thaw procedure.
Kita E; Matsuura H; Masuda S; Tomihata S; Kashiba S
Microbiol Immunol; 1983; 27(1):7-24. PubMed ID: 6346023
[TBL] [Abstract][Full Text] [Related]
4. Immunogenicity of transfer RNA isolated from a two-heptose rough mutant of Salmonella typhimurium LT2 in mouse typhoid infection.
Kita E; Kashiba S
Immunology; 1983 Nov; 50(3):369-76. PubMed ID: 6195095
[TBL] [Abstract][Full Text] [Related]
5. Identification of protective cell surface proteins in ribosomal fractions from Salmonella typhimurium.
Misfeldt ML; Johnson W
Infect Immun; 1979 Jun; 24(3):808-16. PubMed ID: 381202
[TBL] [Abstract][Full Text] [Related]
6. Requirement of the conformational stability of a Salmonella ribosomal vaccine for its mouse protection.
Kita E; Oku D; Nishikawa F; Emoto M; Yasui K; Kashiba S
FEMS Microbiol Immunol; 1991 Aug; 3(4):229-39. PubMed ID: 1931135
[TBL] [Abstract][Full Text] [Related]
7. Experimental study of vaccines against Salmonella typhimurium infection.
Severtsova MK; Stanislavsky ES; El'-Bashir AM; Zaidner IG
J Hyg Epidemiol Microbiol Immunol; 1979; 23(3):318-25. PubMed ID: 393775
[TBL] [Abstract][Full Text] [Related]
8. Purification of immunogenically active ribonucleic acid preparations of Salmonella typhimurium: molecular-sieve and anion-exchange chromatography.
Venneman MR
Infect Immun; 1972 Mar; 5(3):269-82. PubMed ID: 4564556
[TBL] [Abstract][Full Text] [Related]
9. Ribosomal vaccines. I. Immunogenicity of ribosomal fractions isolated from Salmonella typhimurium and Yersinia pestis.
Johnson W
Infect Immun; 1972 Jun; 5(6):947-52. PubMed ID: 4564407
[TBL] [Abstract][Full Text] [Related]
10. Immunogenic dialyzable factor derived from a ribosomal fraction of Salmonella typhimurium III. Analysis of resistance induced by dialyzable factors.
Kita E; Yasui K; Yasui K; Matsuda Y; Matsuda K; Kashiba S
Microbiol Immunol; 1984; 28(7):807-20. PubMed ID: 6436650
[TBL] [Abstract][Full Text] [Related]
11. Acquired immunity against mouse typhoid: genetic restriction and comparative efficacy of ribosomal and conventional vaccines.
Nickol AD; Bonventre PF
J Med Microbiol; 1981 Nov; 14(4):419-33. PubMed ID: 7031251
[TBL] [Abstract][Full Text] [Related]
12. [Immunity to experimental salmonella infection and molecular-weight heterogeneity of antigenic complexes of S. typhimurium].
Severtsova MK; Stanislavskiĭ ES
Zh Mikrobiol Epidemiol Immunobiol; 1977 Feb; (2):79-85. PubMed ID: 324186
[No Abstract] [Full Text] [Related]
13. Immunity to Salmonella typhimurium infection: characterization of antigens in active protection by polyacrylamide gel electrophoresis.
Houchens DP; Wright GL
Infect Immun; 1973 Mar; 7(3):507-11. PubMed ID: 4576683
[TBL] [Abstract][Full Text] [Related]
14. The use of strain LT2-Ml in identifying the protective antigens in a Salmonella typhimurium-derived ribosomal vaccine.
Lin JH; Berry LJ
J Reticuloendothel Soc; 1978 Feb; 23(2):135-43. PubMed ID: 342689
[No Abstract] [Full Text] [Related]
15. Protective immunity induced by porin against Salmonella infection in mice.
Udhayakumar V; Muthukkaruppan V
Indian J Med Res; 1989 May; 89():121-7. PubMed ID: 2550363
[TBL] [Abstract][Full Text] [Related]
16. Isolation and partial characterization of an immunogenic moiety obtained from Salmonella typhimurium.
Venneman MR; Bigley NJ
J Bacteriol; 1969 Oct; 100(1):140-8. PubMed ID: 4898982
[TBL] [Abstract][Full Text] [Related]
17. Variability of protection in inbred mice induced by a ribosomal vaccine prepared from Salmonella typhimurium.
Misfeldt ML; Johnson W
Infect Immun; 1976 Sep; 14(3):652-9. PubMed ID: 786889
[TBL] [Abstract][Full Text] [Related]
18. Protective activity of extracts from Salmonella-R-mutants against Salmonella typhimurium infection in mice. Influence of repeated extractions on the chemical composition and efficacy of the extracts.
Schlecht S; Bhatnagar N
Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1981 Dec; 251(2):196-202. PubMed ID: 6176087
[TBL] [Abstract][Full Text] [Related]
19. Refined live attenuated Salmonella enterica serovar Typhimurium and Enteritidis vaccines mediate homologous and heterologous serogroup protection in mice.
Tennant SM; Schmidlein P; Simon R; Pasetti MF; Galen JE; Levine MM
Infect Immun; 2015 Dec; 83(12):4504-12. PubMed ID: 26351285
[TBL] [Abstract][Full Text] [Related]
20. Isolation and immunological characterization of a 55-kilodalton surface protein from Salmonella typhimurium.
Foulaki K; Gruber W; Schlecht S
Infect Immun; 1989 May; 57(5):1399-404. PubMed ID: 2651306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
